We found that MerTK is extensively expressed in a variety of liver diseases shown in Fig. 4G. MerTK is expressed significantly less in familial hypercholesterolemia, hematoma, and hepatitis B/C (Fig. 4G), indicating MerTK restoration may be a potential therapeutic treatment for these liver diseases. Here, MERTK is linked to hepatitis B virus infection.